VINCENZINA ANDERSON: Open Payments
NPI 1346619897 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 22 payments from 17 companies in 2025. Trend: 2023 $417 · 2024 $479 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 1 | $96 |
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| Astellas Pharma US Inc | 2 | $61 |
| Exelixis Inc. | 2 | $53 |
| Incyte Corporation | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Eisai Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
Products named: XT CDX, CABOMETYX, LYNOZYFIC, Onivyde, Xtandi, Lenvima, VENCLEXTA, Vyloy.
Industry payments across OH — which companies pay providers there.
